All In MedTech

Device Trial Radar · NCT03611907

Comparing Two Types of Needle for Oocytes Retrieval

Prospective Randomized Controlled Trial Comparing Different Needles for Oocyte's Retrieval.

Last checked: Nov 19, 2026Latest source record: Sep 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Mar 6, 2019

Primary completion

May 31, 2020

Study completion Jan 20, 2021

Sponsor

Lead sponsor
Istituto Clinico HumanitasAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 2, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 42 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In the early stages of assisted reproductive technologies (ART), oocyte retrieval was performed via laparoscopy, a cumbersome and expensive process requiring general anesthesia. Today, transvaginal oocyte retrieval for ART is a routine procedure performed under ultrasound guidance. Double-lumen retrieval needles, which are capable of flushing ovarian follicles, were developed to overcome the possibility of oocyte retention within the ovarian follicles and retrieval collection system. Single lumen needles have been introduced and are routinely used by most groups due to their supposed ability to retrieve the same number of oocytes in a shorter operation time.

Conditions

  • Infertility, Female
  • ART

Interventions

  • Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)"Device

    In this intervention a 17-Gauge needle is used to aspirate the follicles

  • Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)"Device

    In this intervention a 17-Gauge needle is used to aspirate follicle, and consequently a 1 mL flush is injected and aspirated twice for each punctured follicle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of retrieved oocytes per procedureTime frame: through study completion, 9 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Paolo Emanuele Levi Setti

    Rozzano, MI, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.